Biological Therapy in Treating Patients With Metastatic Cancer
Status:
Completed
Trial end date:
2000-01-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Biological therapies use different ways to stimulate the immune system and stop
cancer cells from growing. Combining different types of biological therapies, including
interferon alfa, interleukin-2, and tumor infiltrating lymphocytes, may kill more cancer
cells.
PURPOSE: Phase II trial to study the effectiveness of biological therapies, including
interferon alfa, interleukin-2, and tumor infiltrating lymphocytes, in treating patients with
metastatic cancer.